Brief: Phio Pharmaceuticals Corp Says It Receives Non-Compliance Notice From Nasdaq - SEC Filing
Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS CORP SAYS IT RECEIVES NON-COMPLIANCE
NOTICE
FROM NASDAQ - SEC FILING
Source text for Eikon: ID:
Further company coverage: PHIO.O
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing